Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.61 |
| ▸ | ACE | P12821 | 9/20 | 0.54 |
| ▸ | NPY1R | P25929 | 1/20 | 0.54 |
| ▸ | NPY2R | P49146 | 1/20 | 0.54 |
| ▸ | NPY4R | P50391 | 1/20 | 0.54 |
| ▸ | MME | P08473 | 6/20 | 0.51 |
| ▸ | CPA1 | P15085 | 2/20 | 0.51 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.51 |
| ▸ | IL1RN | P18510 | 2/20 | 0.49 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20931094 | 0.89 | NPY4R (0.57) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL19432689 | 0.86 | FOLH1 (0.67) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL10520794 | 0.84 | FOLH1 (0.67) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL32679640 | 0.84 | FOLH1 (0.67) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL30797998 | 0.83 | FOLH1 (0.65) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL30845374 | 0.82 | FOLH1 (0.68) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL29530884 | 0.82 | FOLH1 (0.68) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL29350874 | 0.82 | FOLH1 (0.68) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL29531459 | 0.82 | FOLH1 (0.68) | FOLH1ACENPY1RNPY2RNPY4R | |
| SCHEMBL22498360 | 0.82 | FOLH1 (0.71) | FOLH1ACENPY1RNPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11351264-B2 | PAR2 mimetic peptides and uses thereof | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2022-06-07 | — | — | US | disclosed |
| US-20190117785-A1 | PAR2 MIMETIC PEPTIDES AND USES THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2019-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11351264-B2 | PAR2 mimetic peptides and uses thereof | F2RL1, F2R, F2RL3 | FOLH1 625/4885ACE 710/4885NPY1R 296/4885 |
| US-20190117785-A1 | PAR2 MIMETIC PEPTIDES AND USES THEREOF | F2RL1, F2R, F2RL3 | FOLH1 625/4885ACE 710/4885NPY1R 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.